Biovail to close plants, take charges, mull sales
TORONTO, May 8 (Reuters) - Biovail Corp (BVF.TO: Quote, Profile, Research) (BVF.N: Quote, Profile, Research) said on Thursday that it planned to close two of its operations in Puerto Rico, resulting in charges of $80 million to $100 million in the next few quarters.
Canada's biggest publicly traded drugmaker also said it was exploring the sale of some non-core assets. It plans to spend $600 million in research and development of new treatments through to 2012. ($1=$1.00 Canadian) (Reporting by Scott Anderson)
© Thomson Reuters 2009 All rights reserved
Pledge to support economies
G20 financial leaders pledged to prepare strategies to end emergency support for their economies, but to keep the aid flowing until recovery was assured. Full Article | Related Story
Galleon case
U.S. insider trading probe widens
Fourteen people were charged with fraud and conspiracy in a dramatic widening of an insider trading scandal. Full Article
India
US
UK
